Effect of Transfer Energy Capacitive and Resistive Therapy on Palmar Fibromatosis

Starting soon · Not applicable

Conditions studied: Palmar Fibromatosis

In brief

The objective of the present study is to explore the effect of Transfer Energy Capacitive and Resistive Therapy (TECAR) therapy on pain, range of motion (ROM) and hand function in dupuytren's contracture patients (palmar fibromatosis).

Key facts

Study ID

NCT07443371

Run by

Cairo University

People needed

36

Starts

2026-03-02

Expected to finish

2026-05-30

Last updated by the study team

2026-03-02

Who can join

Age: 40 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ages of patients will be ranged from 40 to 70 years.
• Presence of palpable cords and/or digital contracture ≥ 20° at the metacarpophalengeal joint or Proximal interphalengeal joint joints .
• Clinical diagnosis confirmed by a hand surgeon or relevant specialist.
• All patients will enter the study having their informed consent

You may not qualify if…

• Patient with severe contracture >30° or multiple digit involvement requiring surger.
• History of surgical release (fasciotomy, fasciectomy) or collagenase injection in the affected hand.
• Presence of infection, ulceration, or skin lesions on the treatment area.
• Presence of pacemakers, metal implants, or other electronic implants in the treatment area.
• Active cancer or tumor in the treatment region.
• Pregnancy.
• Conditions such as stroke, Parkinson's disease, or rheumatoid arthritis that may confound results.
• Cognitive impairment, psychiatric illness, or other barriers to protocol adherence

Where it is running

• Peter Milad Haroun — Cairo, Egypt

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.